The peripartum period of a dairy cow is characterized by several physiological and behavioral changes in response to a rapid increase in nutrient demands, to support the final stages of fetal growth and the production of colostrum and milk. Traditionally, the transition period is defined as the period 3 weeks before and 3 weeks after parturition. However, several researchers have argued that the transition period begins at the time of dry-off (~60–50 days prior to calving) and extends beyond the first month post-calving in high producing dairy cows. Independent of the definition used, adequate adaptation to the physiological demands of this period is paramount for a successful lactation. Nonetheless, not all cows are successful in transitioning from late gestation to early lactation, leading to approximately one third of dairy cows having at least one clinical disease (metabolic and/or infectious) and more than half of the cows having at least one subclinical case of disease within the first 90 days of lactation. Thus, monitoring dairy cows during this period is essential to detect early disease signs, diagnose clinical and subclinical diseases, and initiate targeted health management to avoid health and production impairment. In this review, we discuss different strategies to monitor dairy cows to detected unintended disruptions in performance and management strategies that can be implemented to improve the metabolic health and performance of dairy cows during the transition period.

No abstract

________________________________________________________________________________ AbstractThe objective of this study was to evaluate the effect of a progestagen treatment (fluorogestone acetate sponge) alone or in combination with equine chorionic gonadotrophin (eCG) on oestrus response in Red Sokoto (RS) goats. One hundred RS does were treated with 30 mg fluorogestone acetate (FGA) sponges for 14 days. At the end of the progestagen treatment, does that retained the sponges were allocated to two groups; FGAeCG and FGA. The FGAeCG group (n = 28) received 200 IU eCG i.m. concurrently with the sponge removal, while the FGA group (n = 28) did not receive eCG at sponge removal. Oestrus was detected twice daily (at 07:00 -10:00 and 15:00 -18:00) using sexually active bucks for five days following progestagen withdrawal. There was no significant difference in oestrus response between groups FGAeCG (82.1%) and FGA (78.6%). There was a significant difference in the time to the onset (29.3 ± 4.6 and 44.2 ± 6.3 h for the FGAeCG and FGA, respectively) and duration of the induced oestrus period (38.9 ± 5.1 and 22.7 ± 4.6 h for the FGAeCG and FGA groups, respectively). It is concluded that although both groups showed good oestrus synchronization rates, administration of eCG shortened the time to onset of oestrus and increased the duration of oestrus in Red Sokoto does. ________________________________________________________________________________

The objectives of this study were to evaluate the association between hoof lesions and fertility in dairy cows. Lactating Jersey cows (n = 1,639) were enrolled at 20 ± 3 d in milk (D20), examined and treated for presence of hoof lesions (HL), and evaluated for body condition score (BCS). Afterward, they were managed according to standard farm procedures, including estrus detection and presynchronization and a 5 d Cosynch-72 protocol for cows that failed to show estrus. Ovaries were scanned at 27 and 41 ± 3 d in milk, and cows with a corpus luteum greater than 20 mm on at least 1 exam were considered cyclic. At 120 ± 3 d in milk (D120), cows were re-examined for HL and BCS. Cows were classified at D20 according to HL status as healthy (n = 1,197) or having HL (n = 429), and according to HL category as healthy (n = 1,197) or having a sole hemorrhage (n = 280), noninfectious HL (sole ulcer, toe ulcer, or white line disease; n = 113), or infectious HL (digital dermatitis and foot rot; n = 36). Cows with HL at D20 had reduced odds of being cyclic (38.3 vs. 51.9%) and a longer interval from calving to first service (58 vs. 51 d) compared with healthy cows. Cows with infectious HL at D20 had reduced odds of pregnancy to first service (16.7 vs. 38.3%) compared with healthy cows. Cows with sole hemorrhage at D20 were more likely to lose pregnancies between d 32 and 64 after the first service postpartum compared with healthy cows (10.5 vs. 5.2%). Cows with sole hemorrhage at D20 had a smaller hazard of pregnancy (67.9 vs. 75.5%) at 150 d in milk and more days open (88 vs. 77d) compared with healthy cows. To assess the relationship between the development of HL and fertility, cows were classified as healthy (no HL at D20 and D120; n = 308), cured (any HL at D20 and no HL at D120; n = 72), new HL (no HL at D20 and any HL at D120; n = 597), and chronic (any HL at D20 and D120; n = 226). Sole hemorrhage accounted for 93% of new HL. The proportions of cows with HL at D20 and D120 were 26.9 and 68.4%, respectively. We found no evidence for a difference in pregnancy hazard at 150 d in milk between cows that remained healthy (n = 308) and cows that developed new HL (n = 597). Hoof lesions at D20, but not new HL, were associated with decreased odds of cyclicity, longer interval from calving to first service postpartum, and reduced pregnancy hazard in Jersey cows. The effect of an HL diagnosis in early lactation and management to reduce chronic HL in dairy cows warrants further investigation.

Our objective was to evaluate the effects of a non-specific immune stimulant (IS) administered around transportation on health scores (HS), average daily gain (ADG), disease treatment and mortality of Jersey and Jersey-cross calves during the rearing period. Newborn calves (4 d ± 1) were randomly allocated to receive either 1 mL of saline (CON; n = 438), 1 mL of IS before transport (BTIS; n = 431), or 1 mL of IS immediately after transport (ATIS; n = 436). Calves were health scored weekly for 3 weeks after transport. The data were analyzed using multivariable linear mixed models and multivariable logistic regression models. Kaplan-Meier survival analysis was performed for time to event analysis. Treatment, birth weight, breed, site of birth, serum total solids, dam parity, season of enrollment, and metaphylaxis were offered to models. Differences in respiratory and fecal HS, and ADG between treatment groups were not statistically significant. A total of 196 (15.0%) calves were treated at least once for any disease and 52 calves were treated multiple times. The proportion of calves treated for respiratory disease and/or diarrhea were 14.4, 14.4, and 16.2% for BTIS, ATIS and CON groups, respectively. Although the differences in the likelihood of treatment for both respiratory disease and/or diarrhea during the first 9 weeks of life was not statistically different between groups, we observed that more calves in the control group received disease treatments around 15 days of age compared with calves that received IS. The likelihood of treatment for respiratory diseases alone during the first 30 days of life was smaller in the calves that received IS before transportation when compared to the control group. Only 18 (1.4%) calves died within the study period. The calf mortality likelihood was not statistically different between study groups; however, fewer calves in the IS groups died when compared to CON. In conclusion, the use of IS around transportation did not influence weekly HS, ADG, and the number of disease treatments during the rearing period, but administering IS before transportation resulted in fewer treatments of respiratory diseases during the first 30 days post-transport and marginally lower mortality rates during the rearing period.